摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(Z)-4,4,5,5-tetramethyl-2-(4-styrylphenyl)-1,3,2-dioxaborolane | 1221823-28-4

中文名称
——
中文别名
——
英文名称
(Z)-4,4,5,5-tetramethyl-2-(4-styrylphenyl)-1,3,2-dioxaborolane
英文别名
(Z)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)stilbene;4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)stilbene;4,4,5,5-tetramethyl-2-[4-[(Z)-2-phenylethenyl]phenyl]-1,3,2-dioxaborolane
(Z)-4,4,5,5-tetramethyl-2-(4-styrylphenyl)-1,3,2-dioxaborolane化学式
CAS
1221823-28-4
化学式
C20H23BO2
mdl
——
分子量
306.212
InChiKey
HNKMMQPUGYZDTK-KHPPLWFESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.16
  • 重原子数:
    23
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    18.5
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    4-(苯基乙炔基)苯硼酸频哪醇酯nickel(II) nitrate hexahydrate氢气 作用下, 以 乙腈 为溶剂, 120.0 ℃ 、3.0 MPa 条件下, 反应 15.0h, 以91%的产率得到(Z)-4,4,5,5-tetramethyl-2-(4-styrylphenyl)-1,3,2-dioxaborolane
    参考文献:
    名称:
    镍催化炔烃加氢立体发散合成E-和Z-烯烃
    摘要:
    开发了一种使用镍催化剂将炔烃立体发散氢化为E-和Z-烯烃的便捷方案。简单的Ni(NO 3 ) 2 ⋅6 H 2 O作为催化剂前体形成活性纳米粒子,可有效地对多种炔烃进行半加氢,并且对Z-烯烃具有高选择性( Z / E > 99:1)。添加特定的多齿配体(三磷、四磷)后,所得分子催化剂对E-烯烃产物具有高度选择性(E/Z > 99:1)。机理研究表明Z-烯烃选择性催化剂是非均相的,而E-烯烃选择性催化剂是均相的。在后一种情况下,炔烃首先被氢化为Z-烯烃,随后异构化为E-烯烃。该提议得到了密度泛函理论计算的支持。这种合成方法被证明普遍适用于超过 40 个例子,并且可扩展到多克规模的实验。
    DOI:
    10.1002/cssc.201900784
点击查看最新优质反应信息

文献信息

  • Facile Regio- and Stereoselective Hydrometalation of Alkynes with a Combination of Carboxylic Acids and Group 10 Transition Metal Complexes: Selective Hydrogenation of Alkynes with Formic Acid
    作者:Ruwei Shen、Tieqiao Chen、Yalei Zhao、Renhua Qiu、Yongbo Zhou、Shuangfeng Yin、Xiangbo Wang、Midori Goto、Li-Biao Han
    DOI:10.1021/ja2069246
    日期:2011.10.26
    highly stereo- and regioselective hydrometalation of alkynes generating alkenylmetal complex is disclosed for the first time from a reaction of alkyne, carboxylic acid, and a zerovalent group 10 transition metal complex M(PEt(3))(4) (M = Ni, Pd, Pt). A mechanistic study showed that the hydrometalation does not proceed via the reaction of alkyne with a hydridometal generated by the protonation of a
    通过炔烃、羧酸和零价族 10 过渡金属络合物 M(PEt(3))(4) (M =镍、钯、铂)。一项机理研究表明,氢金属化不是通过炔烃与由羧酸与 Pt(PEt(3))(4) 质子化产生的氢化金属反应进行的,而是通过炔烃配位金属络合物与酸。这一发现阐明了长期以来提出的反应机制,该机制通过生成烯基钯中间体和随后在由 Brφnsted 酸和 Pd(0) 配合物的组合催化的各种反应中转化该配合物来进行。
  • [EN] NOVEL LIPOGENIC INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS LIPOGÈNES INÉDITS ET LEURS UTILISATIONS
    申请人:EINSTEIN COLL MED
    公开号:WO2012112670A1
    公开(公告)日:2012-08-23
    The present invention provides resveratrol-based boron-containing analog! methods of use thereof in treatment of dyslipidemias and cancer.
    这项发明提供了基于白藜芦醇的含硼类似物!以及在治疗血脂异常和癌症中的使用方法。
  • Nickel‐Catalyzed Stereodivergent Synthesis of <i>E</i> ‐ and <i>Z</i> ‐Alkenes by Hydrogenation of Alkynes
    作者:Kathiravan Murugesan、Charles Beromeo Bheeter、Pim R. Linnebank、Anke Spannenberg、Joost N. H. Reek、Rajenahally V. Jagadeesh、Matthias Beller
    DOI:10.1002/cssc.201900784
    日期:2019.7.19
    alkynes to E‐ and Z‐alkenes by using nickel catalysts was developed. Simple Ni(NO3)2⋅6 H2O as a catalyst precursor formed active nanoparticles, which were effective for the semihydrogenation of several alkynes with high selectivity for the Z‐alkene (Z/E>99:1). Upon addition of specific multidentate ligands (triphos, tetraphos), the resulting molecular catalysts were highly selective for the E‐alkene products
    开发了一种使用镍催化剂将炔烃立体发散氢化为E-和Z-烯烃的便捷方案。简单的Ni(NO 3 ) 2 ⋅6 H 2 O作为催化剂前体形成活性纳米粒子,可有效地对多种炔烃进行半加氢,并且对Z-烯烃具有高选择性( Z / E > 99:1)。添加特定的多齿配体(三磷、四磷)后,所得分子催化剂对E-烯烃产物具有高度选择性(E/Z > 99:1)。机理研究表明Z-烯烃选择性催化剂是非均相的,而E-烯烃选择性催化剂是均相的。在后一种情况下,炔烃首先被氢化为Z-烯烃,随后异构化为E-烯烃。该提议得到了密度泛函理论计算的支持。这种合成方法被证明普遍适用于超过 40 个例子,并且可扩展到多克规模的实验。
  • Synthesis of Pinacolylboronate-Substituted Stilbenes and their application to the synthesis of boron capped polyenes
    作者:Bhaskar C. Das、Sakkarapalayam M. Mahalingam、Sasmita Das、Narayan S. Hosmane、Todd Evans
    DOI:10.1016/j.jorganchem.2015.08.007
    日期:2015.12
    A series of novel 4,4,5,5-tetramethyl-2-(4-substitutedstyrylphenyl)-1,3,2 dioxaborolane derivatives has been synthesized. 4-(4,4,5,5-tetramethyl-1,3,2-dioxaboratophenyl)-methyl triphenylphosphonium bromide (4) was treated with 3 equiv of tBuONa, various aldehydes in the presence of DMF, and stirred at room temperature 4-6 h to yield the corresponding boron containing stilbene derivatives 1 a-n in 71 -94% yields. A one-pot protocol transformation has also been developed and used this methodology to synthesize boron containing resveratrol analogues. Simple and clean reactions, high yield of the products are the salient features of this methodology. We used this reaction to synthesize the boron capped polyenes. These boron containing polyene systems are potential intermediate to synthesize conjugated polyene as new material for LCD (Liquid Crystal Display) technology. The biological testing of these compounds is currently underway to identify potential therapeutic for Neurodegenerative diseases. (C) 2015 Elsevier B.V. All rights reserved.
  • Design and synthesis of novel pinacolylboronate containing combretastatin ‘antimitotic agent’ analogues
    作者:Bhaskar C. Das、Sakkarapalayam M. Mahalingam、Todd Evans
    DOI:10.1016/j.tetlet.2009.04.003
    日期:2009.6
    We developed a procedure to synthesize pinacolyl boronate containing stilbene derivatives and used this procedure to synthesize boron-containing combretastatin analogues. The key step involves the Wittig reaction of the ylide 4-(4,4,5,5-tetramethyl-1,3,2-dioxaboratophenyl)-methyl triphenylphosphonium bromide 11 with 3,4,5-trimethoxy benzaldehyde in the presence of (1)BuONa in DMF, providing 88% yield. We are now in a position to evaluate the biological activity of these derivatives as modulators of TGF-beta signaling pathways. (C) 2009 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(E,Z)-他莫昔芬N-β-D-葡糖醛酸 (E/Z)-他莫昔芬-d5 (4S,5R)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4R,4''R,5S,5''S)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (1R,2R)-2-(二苯基膦基)-1,2-二苯基乙胺 鼓槌石斛素 高黄绿酸 顺式白藜芦醇三甲醚 顺式白藜芦醇 顺式己烯雌酚 顺式-桑皮苷A 顺式-曲札芪苷 顺式-二苯乙烯 顺式-beta-羟基他莫昔芬 顺式-a-羟基他莫昔芬 顺式-3,4',5-三甲氧基-3'-羟基二苯乙烯 顺式-1,2-二苯基环丁烷 顺-均二苯乙烯硼酸二乙醇胺酯 顺-4-硝基二苯乙烯 顺-1-异丙基-2,3-二苯基氮丙啶 阿非昔芬 阿里可拉唑 阿那曲唑二聚体 阿托伐他汀环氧四氢呋喃 阿托伐他汀环氧乙烷杂质 阿托伐他汀环(氟苯基)钠盐杂质 阿托伐他汀环(氟苯基)烯丙基酯 阿托伐他汀杂质D 阿托伐他汀杂质94 阿托伐他汀内酰胺钠盐杂质 阿托伐他汀中间体M4 阿奈库碘铵 银松素 铒(III) 离子载体 I 钾钠2,2'-[(E)-1,2-乙烯二基]二[5-({4-苯胺基-6-[(2-羟基乙基)氨基]-1,3,5-三嗪-2-基}氨基)苯磺酸酯](1:1:1) 钠{4-[氧代(苯基)乙酰基]苯基}甲烷磺酸酯 钠;[2-甲氧基-5-[2-(3,4,5-三甲氧基苯基)乙基]苯基]硫酸盐 钠4-氨基二苯乙烯-2-磺酸酯 钠3-(4-甲氧基苯基)-2-苯基丙烯酸酯 重氮基乙酸胆酯酯 醋酸(R)-(+)-2-羟基-1,2,2-三苯乙酯 酸性绿16 邻氯苯基苄基酮 那碎因盐酸盐 那碎因[鹼] 达格列净杂质54 辛那马维林 赤藓型-1,2-联苯-2-(丙胺)乙醇 赤松素 败脂酸,丁基丙-2-烯酸酯,甲基2-甲基丙-2-烯酸酯,2-甲基丙-2-烯酸